Recent laboratory studies have shown that low, subtoxic concentrations of iAsIII can inhibit glucose-stimulated insulin expression or secretion by cultured β cells (Díaz-Villaseñor et al. 2006) and a rat insulinoma (INS-1) cell line (Fu et al. 2010). The gene discussed is INS; the disease is pancreatic insulinoma.